|
|
Volumn 36, Issue 12, 2003, Pages 1514-1515
|
|
A mountain out of a Molehill: Do we treat acute leptospirosis, and if so, with what?
a,b,c
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPICILLIN;
BETA LACTAM ANTIBIOTIC;
CEFTRIAXONE;
DOXYCYCLINE;
PENICILLIN DERIVATIVE;
VIRULENCE FACTOR;
ANTIINFECTIVE AGENT;
ALLERGY;
ANTIMICROBIAL THERAPY;
BACTERIAL TRANSMISSION;
BRAIN DISEASE;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG EFFICACY;
HUMAN;
HYPERKALEMIA;
LABORATORY DIAGNOSIS;
LEPTOSPIRA INTERROGANS;
LEPTOSPIROSIS;
LUNG HEMORRHAGE;
MEDICAL DECISION MAKING;
MORTALITY;
MULTIPLE ORGAN FAILURE;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
RESPIRATORY DISTRESS;
ACUTE DISEASE;
COMPARATIVE STUDY;
ECONOMICS;
HEALTH CARE COST;
ACUTE DISEASE;
ANTI-BACTERIAL AGENTS;
CEFTRIAXONE;
COST-BENEFIT ANALYSIS;
HEALTH CARE COSTS;
HUMANS;
LEPTOSPIROSIS;
PENICILLINS;
|
|
EID: 0038209490
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/375275 Document Type: Note |
|
Times cited : (37)
|
|
References (6)
|
